A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy
- 30 November 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (11), 1767-1773
- https://doi.org/10.1016/0360-3016(87)90176-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Preparation of a 211 AtIgU conjugate which is stable in vivoThe International Journal of Applied Radiation and Isotopes, 1984
- Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At− in mice with a transplanted rectal adenocarcinomaThe International Journal of Applied Radiation and Isotopes, 1984
- Distribution of and physiologic factors that affect 131I-antiferritin tumor localization in experimental hepatomaInternational Journal of Radiation Oncology*Biology*Physics, 1984
- 211At radiocolloid therapy: Further observations and comparison with radiocolloids of 32P, 165Dy, and 90YInternational Journal of Radiation Oncology*Biology*Physics, 1984
- LOCALISATION OF GLIOMA BY HUMAN MONOCLONAL ANTIBODYThe Lancet, 1982
- The specific inhibition of cellular clonogenic proliferation using 211At labelled lectins and antibodies—IInternational Journal of Nuclear Medicine and Biology, 1982
- Antiferritin IgG Antibody for Isotopic Cancer TherapyOncology, 1981
- Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignanciesInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Cell Survival Following Multiple-track Alpha Particle IrradiationInternational Journal of Radiation Biology, 1979